Slide 1: Noumi Limited 2025 Results
Noumi Limited 2025 Results 26 August 2025
Slide 2: Important notice and disclaimer
Important notice and disclaimer Summary Information Only This presentation criteria contains general information about Noumi Limited and its consolidated entities (“Noumi Limited”) and its activities current as at the date of this presentation. It is provided in summary and does not purport to be co
Slide 3: Agenda
Agenda FY25 OVERVIEW 01 COMPANY PROGRESS 02 FINANCIAL PERFORMANCE 03 STRATEGY 04 CLOSING REMARKS 05 Noumi Limited 2025 Results 3
Slide 4: FY25 Overview
FY25 Overview Noumi Limited 2025 Results 4
Slide 5: Strategy delivers improved revenue and earnings
Strategy delivers improved revenue and earnings Our strategy is delivering. Adjusted operating EBITDA of $57.4m up 13.0% on FY24. Plant-based Milks delivers record adjusted operating EBITDA of $50.3m up 1.7% Milklab brand lifted overall plant-based sales by 6.7% Dairy & Nutritionals adjusted operati
Slide 6: Financial Highlights
FINANCIAL HIGHLIGHTS $57.4m $11.1m $50.3m Adj Op EBITDA 1,2 Dairy & Nutritionals Adj Op EBITDA 1 Plant-based Milks Adj Op EBITDA 1 $6.6m $5.6m $0.9m $595.8m $413.8m $182.0m Net Revenue Dairy & Nutritionals Net Revenue Plant-based Milks Net Revenue $6.0m $1.6m $4.4m ($150.0m) Statutory net loss after
Slide 7: Company Progress
Company Progress Noumi Limited 2025 Results 7
Slide 8: Strategy shifting to growth
Strategy shifting to growth Reset phase complete – Legacy litigation matters closed Transformation achievements – Dairy & Nutritionals three years of improving results. Commodity prices recover Domestic retail initiatives – Milklab launched into Australian retail, growing revenue by $9.3m Plant-base
Slide 9: Further development of our team
Further development of our team Over 500 talented team members around the globe Increased participation in engagement survey and leadership workshops Safety metrics improved Frontline leadership development program continued during FY25, building a stronger team Supporting our team with updated tool
Slide 10: The Healthier Tomorrow Plan
The Healthier Imagining a Healthier Tomorrow is Noumi’s strategic Tomorrow Plan purpose and our guiding light as we seek to create a positive impact by promoting: For our consumers Through our farmers For our people & communities & production processes & stakeholders These Principles are the foundat
Slide 11: Noumi – Key manufacturing sites
Noumi – Key manufacturing sites Dairy & Nutritionals Plant-based Milks Shepparton, VIC Ingleburn, NSW • Noumi Nutritionals is a leading Australian • Our state-of-the-art facility in Ingleburn, manufacturer of quality Long-life dairy New South Wales specialises in the products and premium protein dev
Slide 12: Our Business Units
Our Business Units
Slide 13: Our Brands
Noumi has a broad portfolio of strong Our Brands brands that meet differing consumer needs and occasions across multiple markets.
Slide 14: Financial Performance
Financial Performance Noumi Limited 2025 Results 14
Slide 15: FY25 Earnings
FY25 Earnings FY25 ($m) FY24 ($m) Change ($m) Net revenue up $6.0m – Milklab overall sales up 5.8%; Domestic Long-life dairy up 9.3% and plant-based export sales Net revenue 595.8 589.8 6.0 up 18.8% Adj operating EBITDA1, 2 57.4 50.8 6.6 Adjusted operating EBITDA $57.4m up 13.0% with Non-operating i
Slide 16: Financial Performance | Plant-based Milks
Financial Performance | Plant-based Milks Financial results Summary of performance FY25 ($m) FY24 ($m) Change($m) Change Record revenues and earnings reflect recent initiatives to grow Net revenue 182.0 177.6 4.4 2.5% in new channels, geographies and products Adjusted operating EBITDA1 50.3 49.4 0.9
Slide 17: Financial Performance | Dairy & Nutritionals
Financial Performance | Dairy & Nutritionals Financial results Summary of performance FY25 ($m) FY24 ($m) Change ($m) Change Positive adjusted operating EBITDA doubled from $5.5m in Net revenue 413.8 412.2 1.6 0.4% FY24 to $11.1m despite challenging industry conditions Net revenue excl. Traded Milk
Slide 18: FY25 Balance Sheet
FY25 Balance Sheet Cash and Borrowings Cash at bank of $16.2m with undrawn finance facility of FY25 ($m) FY24 ($m) Change ($m) $10.0m provides liquidity for operations based on current conditions and expectations Cash and cash equivalents 16.2 14.6 1.6 Financial debt (excl. Convertible Notes) (83.3)
Slide 19: Cash Flow
Cash Flow Summary FY25 ($m) FY24 ($m) Cash generated from trading 67.0 41.6 Net cash flow from operations very strong. Improved trading Net finance costs (18.8) (17.6) results and tightly managed working capital. Property, plant and equipment (4.9) (5.0) Income taxes paid (3.2) - Working capital hig
Slide 20: Strategy
Strategy Noumi Limited 2025 Results 20
Slide 21: Strategy | Plant-based Milks
Strategy | Plant-based Milks Focus Areas Invest in brand strength to fortify Milklab’s leadership position in out-of-home channel Invest in out-of-home sales team capabilities and tools to complement brand investment Continue to expand Milklab in retail to build further on the momentum achieved in t
Slide 22: Strategy | Dairy & Nutritionals
Strategy | Dairy & Nutritionals Focus Areas Focus on contract pack customers. Service, quality, reliability and efficiency Value added projects to improve returns from milk components and reduce exposure to commodity pricing Leverage the health benefits of PUREnFERRIN Lactoferrin to create new produ
Slide 23: Outlook
Outlook Looking ahead, with the legacy issues resolved for the Company, Noumi will be focusing on investment in the Milklab brand for the longer term by building on successful initiatives underway, including marketing investment to support expansion into new channels and product development, as well
Slide 24: jos
jos DY eS OUI) ey Aas Imagiping d healthier tomorraw
Slide 25: Appendix
Appendix Noumi Limited 2025 Results 25
Slide 26: Profit and Loss Summary
Profit and Loss Summary Non-operating items incl. restructuring & litigation2 FY25 ($m) FY24 ($m) FY25 ($m) FY24 ($m) 1 Adjusted operating EBITDA 57.4 50.8 Restructuring expenses (including ERP) (7.1) (0.1) Non-operating items incl. restructuring & litigation 2 (14.8) (6.4) ASIC penalty expenses - (
Slide 27: Imagining a healthier tomorrow
noum:. Imagining a healthier tomorrow